Robins Chad M's Form 4 filing
Adaptive Biotechnologies Corp (ADPT) · filed Mar 6, 2025
- Accession no.
- 0001062993-25-004809
- Filed
- Mar 6, 2025
- Trade date
- Mar 4-6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $1.60M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robins Chad MCIK 0001780649 | Director, Officer (CEO and Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Common Stock | AGrant or awardAcquired | +355,000 | $0.00 | $0 | 2,931,701 | Direct | |
| Mar 5, 2025 | Common Stock | SSaleDisposed | −81,206 | $6.98 | −$566,817.88 | 2,850,495 | Direct | |
| Mar 5, 2025 | Common Stock | SSaleDisposed | −36,145 | $6.99 | −$252,653.55 | 2,814,350 | Direct | |
| Mar 5, 2025 | Common Stock | AGrant or awardAcquired | +247,117 | $0.00 | $0 | 3,061,467 | Direct | |
| Mar 6, 2025 | Common Stock | SSaleDisposed | −102,218 | $7.64 | −$780,945.52 | 2,959,249 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.